Achieving Data Quality and Integrity in Clinical Trials Involving High Consequence Pathogens — Clinical Course

In-Person (3 days) & Virtual (2 days) | July 30-Aug 1

UNMC’s Global Center for Health Security and the FDA-University of Texas Medical Branch Collaborative Program are hosting the FDA-sponsored “Achieving Data Quality and Integrity in Clinical Trials Involving High Consequence Pathogens” clinical course from July 30-August 1, 2024. There are no fees associated with course attendance, and the event is in-person and virtual. However, seating for in-person attendance is limited.

This three day (two days for virtual attendees) interactive course allows participants to enhance knowledge and integrate practical considerations for the planning and operation of clinical research protocols involving medical countermeasures for high consequence pathogens. Course participants acquire knowledge through innovative learning platforms and problem-based scenarios that help identify and mitigate barriers to data quality and integrity in domestic and international barrier environments.

Day 3 of the course (for in-person attendees only) will focus on Workplace Risk Assessments, Donning and Doffing of high level PPE, Waste Management, and Simulation Exercises in Mock Barrier Environment. These activities will take place at UNMC’s Training, Simulation, and Quarantine Center (TSQC). The Training, Simulation, and Quarantine Center provides a 6-bed high-fidelity simulated biocontainment unit training center, emergency operations center, laboratory, multipurpose room for incident management and skills training, and is the only federally-funded, 20-bed National Quarantine Unit (NQU) in the United States.

This course is submitted for Continuing Education credits for nurses and quality assurance professionals. Details will be posted closer to course dates and more information can be found on the event webpage.